Philips CPAP Lawsuit: Settlements and What Remains (2026)

What the Case Was About

The Philips CPAP lawsuit centered on one part hidden inside Philips Respironics sleep and breathing machines. CPAP and BiPAP machines push air through a mask to keep the airway open during sleep, and ventilators help people who cannot breathe well on their own. To keep these devices quiet, Philips lined many of them with polyester-based polyurethane foam, known as PE-PUR.

According to Philips, that foam could break into small particles or release chemical gases that users might swallow or inhale. The company listed possible risks such as headache, irritation, inflammation, breathing problems, and possible toxic and cancer-causing effects. Heat, humidity, and unapproved cleaning methods like ozone could speed up the breakdown.

The recall covered about 15 million devices worldwide, and the FDA labeled it a Class I recall – its most serious category. Users sued on three fronts: people who became ill sought payment for their injuries, buyers wanted money back for machines they could no longer safely use, and a class of users asked for help paying for future health checks.

How the Federal Cases Were Combined

With similar suits piling up across the country, a federal panel sent them to one judge on October 8, 2021. The combined case became MDL No. 3014, In re: Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation, in the Western District of Pennsylvania. Senior U.S. District Judge Joy Flowers Conti has overseen it from the start.

An MDL, short for multidistrict litigation, is not a class action. Each person keeps their own lawsuit, but the cases share evidence gathering and pretrial rulings. The defendants were Philips RS North America LLC, Koninklijke Philips N.V., Philips North America LLC, Philips Holding USA, Inc., and Philips RS North America Holding Corporation.

As of September 1, 2026, the JPML counted 624 active cases in MDL No. 3014 and 1,033 filed in total. That count covers federal lawsuits only.

Philips CPAP Lawsuit Settlements

Philips resolved the litigation through three separate lawsuit settlements, each covering a different type of claim.

Economic Loss Settlement

The first deal went to buyers. Announced on September 8, 2023, it committed a minimum of $479 million to people who purchased recalled machines, plus $15 million to help them replace devices. It covered money losses only, not injuries. The court gave final approval on April 25, 2024.

Medical Monitoring Settlement

The second deal covered U.S. users of recalled devices sold between 2008 and 2021. Under the court-approved class notice, Philips paid $25 million into a fund for a 15-year Medical Advancement Program. Class members could not opt out, and the deal did not release anyone's personal injury claims.

Personal Injury Settlement

The largest piece resolved injury claims. The April 2024 agreement set aside $1.1 billion in total for the injury and medical monitoring claims, and Philips did not admit that its devices caused any harm. The master settlement agreement, signed on May 9, 2024, set up a private payment program that runs outside the courtroom.

To qualify, claimants generally had to appear on court identification lists by June 21, 2024, and register by January 31, 2025. Both the injury and medical monitoring deals became final in January 2025, and Philips said it paid them in full during the first half of that year.

The FDA Consent Decree

Regulators acted on a separate track. On April 9, 2024, a federal court entered a consent decree – a court-enforced agreement – against Philips Respironics. It limits production and sales at the company's facilities in Pennsylvania and California until Philips meets FDA requirements, and it calls for independent testing of the replacement foam.

In mid-2025, Philips also reported that a U.S. Department of Justice investigation tied to Respironics was still ongoing.

What Happens to the Cases That Did Not Settle

Not everyone joined the settlement. People who kept their own suits, called Litigating Plaintiffs, now face a key test: showing that the foam can cause their illnesses at all. Lawyers call this general causation.

Under the April 2026 order, challenges to each side's causation experts were due August 27, 2026, with responses due September 24 and replies due October 15. The judge will then decide whether the plaintiffs' experts meet federal evidence rules. The same schedule covers whether U.S. courts can hear claims against the parent company, Koninklijke Philips N.V. Cases of plaintiffs who did not meet the court's paperwork rules by May 15, 2026 are on hold until those rulings.

The court has held plaintiffs to its deadlines. In June 2026, it closed 40 cases for good after the plaintiffs ignored an order, and in September 2026 it put one lead lawyer in charge of shared pretrial work for those still litigating.

Timing matters for anyone who never filed. Each state sets a deadline to sue, called a statute of limitations, and the clock often starts when a person learns about an injury and its likely cause. With the recall public since 2021, many of those deadlines may already have passed.